STS, created in 2005 (United States), from 20 sister brands and 2617 competing brands. The STS brand is owned by DexCom, a company listed in New York. STS is part of the Medical Diagnostics & Research activity sector.
Investment simulator :
Portfolio valuation
DexCom
(STS)
over 5 years*
USD 509.04